Acura receives two $100K loans from AD Pharma; warns of possible operations halt if no further financing by Aug 2025

ACURA PHARMACEUTICALS, INC

Principal on secured note rises to $8,394,279 with ~$740K accrued interest; interest rate 5.25%.
Loans of $100K each on July 3 and July 18, 2025 from Abuse Deterrent Pharma, LLC (AD Pharma).
Without additional financing by early August 2025, company may furlough employees or seek bankruptcy protection.
AD Pharma owns ~65% of outstanding common stock (excludes warrant for 10M shares).
Funds used for day-to-day operations; no assurance of further financing.

item 1.01item 2.01item 2.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.